https://www.selleckchem.com/products/Aminocaproic-acid(Amicar).html Due to progressive decline in activities of daily living, patients with intractable neurological diseases require long-term medical treatment with care and support. For continued medical- and nursing-care service provision desirable for patients, attempts have been made to establish a cooperation network system between specialized medical institutions and community healthcare institutions. This article describes the role of medical institutions responsible for home care in this system based on clinical practice.Diagnosis of possible neurosarcoidosis (NS) involves assessment of clinical presentation suggestive of NS and exclusion of other diagnoses, whereas its definitive diagnosis is challenging and it requires positive nervous system histology. Due to an exceptionally low incidence, limited data are available on the optimal therapeutic options for NS. NS is commonly associated with other sarcoidosis forms; however, the patients with NS experience more frequent relapses than with other organs sarcoidosis. While corticosteroid therapy is considered as the first-line of treatment for NS, secondary treatment options with immunosuppressive agents such as methotrexate, azathioprine, mycophenolate mofetil and tumor necrosis factor (TNF)-α inhibitors are considered based on the severity of NS manifestations and the disease status.Sarcoidosis is a systemic granulomatous inflammation of unknown etiology that is reported in all age groups but with a higher prevalence in young adults. Sarcoidosis frequently involves the lungs, eyes, lymph nodes and skin. The involvement of the central nervous system (CNS) is reported with other sarcoidosis forms. Although only nervous system involvement presenting as CNS lesions are seen in 1% of cases, autopsy studies have confirmed CNS lesions in up to 25% of the cases. The nervous system including the brain, spinal cord, cerebral meninges, cranial nerves, pituitary gland, p